ATEC announces closure of public share issue

CARLSBAD, California, October 27, 2023–(BUSINESS WIRE)–Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions aimed at revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 14,300,000 shares of its common stock at a public offering price of $ 10.50 per share.

Morgan Stanley, TD Cowen, Barclays and Stifel acted as joint book-running managers on the offering.

ATEC received gross proceeds of $150,150,000 from the offering.

The shares of common stock were offered pursuant to a registration statement on Form S-3 (File No. 333-271336) previously filed with and declared effective by the Securities and Exchange Commission (the “SEC”). The offering was made by means of a prospectus supplement and the accompanying prospectus. A preliminary prospectus supplement, a final prospectus supplement and a companion prospectus relating to the offering have previously been filed with the SEC and are available on the SEC’s website at www.sec.gov. The preliminary prospectus supplement, the final prospectus supplement and the accompanying base prospectus are available on the SEC’s website and may also be obtained from Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014; Cowen and Company, LLC, 599 Lexington Avenue, New York, New York 10022, by telephone at (833) 297-2926 or by email at prospectus_ecm@cowen.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at 1-888-603-5847 or by email at barclaysprospectus@broadridge.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About ATEC

ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging SAS and SafeOp Surgical, Inc., is a medical device company committed to revolutionizing the approach to spine surgery through clinical differentiation. ATEC’s Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the company’s growing AlphaInformatiX Platform to better inform surgery and achieve the goals of spine surgery more safely and reproducibly. ATEC’s vision is to be the standard bearer in the spine field.

Contacts

Company contact:
J. Todd King
Finance Director
investorrelations@atecspine.com

Investor/media contact:
Tina Jacobsen, CFA
Investor Relations
(760) 494-6790
investorrelations@atecspine.com